GPAT3
Basic information
Region (hg38): 4:83535914-83605875
Previous symbols: [ "AGPAT9" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GPAT3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 22 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 22 | 0 | 1 |
Variants in GPAT3
This is a list of pathogenic ClinVar variants found in the GPAT3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-83536650-A-T | not specified | Uncertain significance (Jul 20, 2022) | ||
4-83536720-G-A | not specified | Uncertain significance (Dec 26, 2023) | ||
4-83536735-A-G | not specified | Uncertain significance (Jun 02, 2024) | ||
4-83544564-C-A | not specified | Uncertain significance (Nov 22, 2021) | ||
4-83544578-A-G | Benign (Jul 16, 2018) | |||
4-83544579-T-G | not specified | Uncertain significance (Sep 14, 2022) | ||
4-83581577-A-G | not specified | Uncertain significance (Mar 19, 2024) | ||
4-83581580-A-G | not specified | Uncertain significance (Oct 13, 2023) | ||
4-83581583-C-T | not specified | Uncertain significance (Oct 26, 2021) | ||
4-83581760-A-T | not specified | Uncertain significance (Jul 14, 2021) | ||
4-83581786-T-G | not specified | Uncertain significance (Aug 20, 2023) | ||
4-83581790-T-C | not specified | Uncertain significance (Mar 19, 2024) | ||
4-83581796-G-A | not specified | Uncertain significance (May 18, 2023) | ||
4-83581807-C-T | not specified | Uncertain significance (Dec 22, 2023) | ||
4-83587272-T-C | not specified | Uncertain significance (Apr 20, 2024) | ||
4-83588253-C-T | not specified | Uncertain significance (Dec 18, 2023) | ||
4-83590222-G-A | not specified | Uncertain significance (May 18, 2022) | ||
4-83594875-A-T | not specified | Uncertain significance (Sep 17, 2021) | ||
4-83594910-T-A | not specified | Uncertain significance (Jun 16, 2024) | ||
4-83596883-A-C | not specified | Uncertain significance (Apr 04, 2023) | ||
4-83596887-A-G | not specified | Uncertain significance (Jul 14, 2022) | ||
4-83596907-C-T | not specified | Uncertain significance (Dec 11, 2023) | ||
4-83597504-G-A | not specified | Uncertain significance (Mar 18, 2024) | ||
4-83597508-C-T | not specified | Uncertain significance (Dec 13, 2023) | ||
4-83598671-A-G | not specified | Uncertain significance (Jan 10, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GPAT3 | protein_coding | protein_coding | ENST00000395226 | 12 | 69962 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.80e-12 | 0.340 | 125544 | 0 | 203 | 125747 | 0.000807 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.442 | 220 | 239 | 0.920 | 0.0000120 | 2820 |
Missense in Polyphen | 72 | 75.444 | 0.95436 | 860 | ||
Synonymous | -1.32 | 103 | 87.3 | 1.18 | 0.00000443 | 854 |
Loss of Function | 1.12 | 21 | 27.3 | 0.768 | 0.00000159 | 295 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00137 | 0.00137 |
Ashkenazi Jewish | 0.000694 | 0.000695 |
East Asian | 0.00122 | 0.00120 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000900 | 0.000897 |
Middle Eastern | 0.00122 | 0.00120 |
South Asian | 0.000785 | 0.000784 |
Other | 0.00130 | 0.00130 |
dbNSFP
Source:
- Function
- FUNCTION: May transfer the acyl-group from acyl-coA to the sn-1 position of glycerol-3-phosphate, an essential step in glycerolipid biosynthesis. Also transfers the acyl-group from acyl-coA to the sn-2 position of 1-acyl-sn-glycerol-3-phosphate (lysophosphatidic acid, or LPA), forming 1,2-diacyl-sn-glycerol-3- phosphate (phosphatidic acid, or PA). {ECO:0000269|PubMed:17002884, ECO:0000269|PubMed:17170135, ECO:0000269|PubMed:19318427}.;
- Pathway
- Glycerolipid metabolism - Homo sapiens (human);Glycerophospholipid metabolism - Homo sapiens (human);HIF1A and PPARG regulation of glycolysis;Metabolism of lipids;Metabolism;CDP-diacylglycerol biosynthesis;triacylglycerol biosynthesis;Glycerophospholipid biosynthesis;Phospholipid metabolism;Synthesis of PA
(Consensus)
Recessive Scores
- pRec
- 0.115
Intolerance Scores
- loftool
- rvis_EVS
- -0.09
- rvis_percentile_EVS
- 46.99
Haploinsufficiency Scores
- pHI
- 0.131
- hipred
- N
- hipred_score
- 0.316
- ghis
- 0.431
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Gpat3
- Phenotype
- homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- phosphatidic acid biosynthetic process;CDP-diacylglycerol biosynthetic process;triglyceride biosynthetic process;regulation of TOR signaling
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;integral component of membrane
- Molecular function
- 1-acylglycerol-3-phosphate O-acyltransferase activity;glycerol-3-phosphate O-acyltransferase activity;sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity